R&D and ADL centre has certified by DSIR, Govt. of India.
2020-10-16 08:52:49
OSD Plant at Thane has been renewed with WHO GMP Certificate by CDSCO by Government of India
2025-09-01 08:10:04
OSD plant at Thane has been approved by Eurasian authority for EAEU GMP for Tablet, Capsule, Liquid Oral and Ointment & Cream Facility
2025-09-01 08:12:56
Company has Successfully started the opration at its Goa Plant for Oncology Products
Launch of two products in our brand and for contract manufacturing Oseltamavir caps, 30mg, 45mg and 75 mg And Favipiravir 200 mg/400mg/800mg Tablet.
Today Lok-Beta is a key player in the Indian market, with a wide range of products in various segments such as Anti-Inflammatory, Antibiotics, Anti-Histaminics, Antitussive and planning to enter in new segment Neutraceuticals, Antimalarial, Antihypertensive and Anti-Diabetic, Gastroenterology.
Lok-Beta enjoys a strong rapport with the medical profession including specialist, who have accepted Lok-Beta's product for their High quality, efficacy and affordability. Lok-Beta has a strong presence in the states of UP, Jharkhand, Bihar, MP. Assam, Orissa,Punjab, Rajasthan and Maharashtra aiming to penetrate PAN India market.
The majority of products marketed are for the treatment and/or prevention of chronic and recurrent illness. Lok-Beta concentrates on the following therapeutic area with niche molecules.